We, however, found that the estimated risk function for the administration period of short-acting BZDs and the duration of anxiety disorders in Figure 4 D showed the same, almost significant, diphasic risk variations as those estimated with the MKL2 model, confirming the robustness of the result.
← all excerpts
Benzodiazepine-related dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records.
1
—
—